Phase I Pharmacokinetic Study of Niraparib in Chinese Patients with Epithelial Ovarian Cancer

LESSONS LEARNED: Pharmacokinetics characteristics of niraparib in Chinese patients were similar to those in white patients. Niraparib could be well tolerated by Chinese patients, and adverse events were manageable in this study. Population pharmacokinetics analysis indicated that baseline body weigh...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Zhang, Jian, Zheng, Hong, Gao, Yunong, Lou, Ge, Yin, Rutie, Ji, Dongmei, Li, Wenhua, Wang, Wei, Xia, Bairong, Wang, Danqing, Hou, Jianmei, Yan, James, Hei, Yongjiang, Zhang, Zhi‐Yi, Milton, Ashley, Wu, Xiaohua
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2019
Matèries:
Clinical Trial Results
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6964144/
https://ncbi.nlm.nih.gov/pubmed/31439812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0565
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars